Cited by 50Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia ResearchCancer Genomics and Diagnostics

Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma

Maura, Francesco, Rustad, Even H., Yellapantula, Venkata, Łuksza, Marta, Hoyos, David, Maclachlan, Kylee H., Diamond, Benjamin T., Greenbaum, Benjamin D. +4 more·2020·Leukemia

Integrity signals

Registry

Crossref · 10.1038/s41375-019-0689-0

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Different patients might experience different exposure in time and intensity in the germinal center, potentially reflecting unique interaction with the external environment.

    “Importantly, based on the different number of GC mutations observed across hundreds of WGS, it has been shown that different patients might experience different exposure in time and intensity, potentially reflecting unique interaction with the external environment.12,13,15,72,73”

    From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [72]

  • Non-synonymous mutations in oncogenes mediated by AID can also be acquired before HY.

    “Additionally, non-synonymous mutations in oncogene mediated by AID can also be acquired before HY.72”

    From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [72]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maura, F., Rustad, E. H., Yellapantula, V., Łuksza, M., Hoyos, D., Maclachlan, K. H., Diamond, B. T., Greenbaum, B. D., Morgan, G., Lesokhin, A., Papaemmanuil, E., & Landgren, O.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • Tisch Cancer Institute (US)
  • NYU Langone Health (US)
Corresponding author
Maura, Francesco
Venue
Leukemia
Published
2019-12-13
Volume
34
Issue
5
Pages
1476-1480
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W2995424845
Cited by
50
References
2
Citations by year
2026: 1 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 12 · 2020: 10 · 2019: 1
FWCI
5.12
Type
journal article
Language
en
Open access
closed
Locations
  • Leukemia (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA 008748)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
driver mutations, multiple myeloma, somatic mutations, clonal evolution
MeSH terms
Whole Genome Sequencing, AICDA (Activation-Induced Cytidine Deaminase), Cytidine Deaminase, DNA Mutational Analysis, Humans, Multiple Myeloma, Mutation, Biomarkers, Tumor, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review